Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 6 (HMGN2P6)

Target
HMGN2P6
Molecular classification
Pseudogene, Non-coding DNA
01

Overview

High mobility group nucleosomal binding domain 2 pseudogene 6 (HMGN2P6) is a processed pseudogene related by sequence homology to the high mobility group nucleosomal binding domain 2 (HMGN2) gene but does not encode a functional protein. Pseudogenes like HMGN2P6 typically arise by duplication or retrotransposition events, leading to loss of protein-coding capacity due to mutations such as premature stop codons or frameshifts. Although most pseudogenes are nonfunctional, there is increasing evidence that some can regulate their parental genes through various mechanisms at the RNA level, including acting as competitive endogenous RNAs (ceRNAs) or antisense transcripts that modulate gene expression. There is no evidence that HMGN2P6 functions in this regulatory capacity or has any role in disease pathogenesis; it is not recognized as a therapeutic target, receptor, enzyme, transporter, or transcription factor. HMGN2P6 is primarily of genomic and evolutionary interest rather than clinical or pharmacological relevance.

Other names
HMGN2 pseudogene 6HMGN2P6
02

Biological functions

Acts as a non-coding genomic element with possible regulatory roles at the RNA level (such as regulation of parental gene expression via antisense transcripts or acting as a microRNA decoy as described for other pseudogenes)Does not encode a protein product.
03

Disease associations

No direct evidence for involvement in disease.Other pseudogenes have indirect regulatory effects on diseases like cancer or diabetes through modulation of parental gene expression

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 6 (HMGN2P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 6 (HMGN2P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call